Treatment of Infertility by Collagen Scaffold Loaded With Autologous Bone Marrow Stem Cells
Primary Purpose
Infertility, Intrauterine Adhesions, Endometrial Dysplasia
Status
Unknown status
Phase
Phase 4
Locations
China
Study Type
Interventional
Intervention
autologous bone marrow stem cells
Sponsored by
About this trial
This is an interventional treatment trial for Infertility
Eligibility Criteria
Inclusion Criteria:
- Infertility caused by serious intrauterine adhesions or endometrial dysplasia
- Hysteroscopy examination confirmed intrauterine adhesions or endometrial dysplasia
- Monitoring of endometrial cycle
- Sign a consent form
- Follow the test plan and follow-up process
Exclusion Criteria:
- Abnormal chromosome karyotype
- Congenital uterine malformations
- Severe endometriosis
- Severe adenomyosis
- Contraindications to pregnancy
- Contraindications to bone marrow collection
- Contraindications to hormone replacement therapy
- Medical history of pelvic tumors or receiving pelvic radiotherapy
- Unable to adhere to the hospital examination and follow-up, or carrying on other treatment during follow-up period
Sites / Locations
- Nanjing Drum Tower HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
autologous bone marrow stem cells
Arm Description
Using collagen scaffold loaded with autologous bone marrow stem cells to treat severe intrauterine adhesions or endometrial dysplasia.
Outcomes
Primary Outcome Measures
Reduction of intrauterine scar area,the change of intrauterine adhesion
hysteroscope ,understanding improvement of uterine cavity form,the degree and nature of adhesion or the vanishment of intrauterine adhesion,and the reduction of scar and its area,comparing with pre-operation
Secondary Outcome Measures
The change of endometrial thickness
Measure the endometrial thickness and endometrial blood supply during ovulation by ultrasound by the same trained medical sonographers,comparing with pre-operation.
The change of endometrial thickness
Measure the endometrial thickness and endometrial blood supply during ovulation by ultrasound by the same trained medical sonographers,comparing with pre-operation.
menstrual blood volume The change of menstrual blood volume
Understanding the menstrual blood volume after surgery ,the number of sanitary napkins per day ,and number of days,comparing with pre-operation.
Full Information
NCT ID
NCT02204358
First Posted
July 26, 2014
Last Updated
July 28, 2014
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
1. Study Identification
Unique Protocol Identification Number
NCT02204358
Brief Title
Treatment of Infertility by Collagen Scaffold Loaded With Autologous Bone Marrow Stem Cells
Official Title
Clinical Study of the Treatment of Infertility Caused by Severe Intrauterine Adhesions by Collagen Scaffold Loaded With Autologous Bone Marrow Stem Cells
Study Type
Interventional
2. Study Status
Record Verification Date
July 2014
Overall Recruitment Status
Unknown status
Study Start Date
January 2012 (undefined)
Primary Completion Date
July 2014 (Actual)
Study Completion Date
December 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Study of the treatment of infertility caused by severe intrauterine adhesions or endometrial dysplasia by collagen scaffold loaded with autologous bone marrow stem cells, and to provide clinical evidence for the treatment of uterine infertility
Detailed Description
Infertility is defined as a women fails to become pregnant after having a normal sex life for two years without contraception. There is no effective treatment to the infertility caused by severe intrauterine adhesions or endometrial dysplasia which affects embryos implantation. The existing drugs, physical or surgical treatments had no significant effects to severe intrauterine adhesions.Collagen is the main component of the extracellular matrix with good biocompatibility, and it has been approved for the reparation of skin and oral mucosa by State Food and Drug Administration. Bone marrow stem cells have been used in the clinical treatment of blood diseases, and achieved good results. In this study, collagen scaffold and autologous bone marrow stem cells are combined, and they showed good biological safety
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility, Intrauterine Adhesions, Endometrial Dysplasia
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
autologous bone marrow stem cells
Arm Type
Experimental
Arm Description
Using collagen scaffold loaded with autologous bone marrow stem cells to treat severe intrauterine adhesions or endometrial dysplasia.
Intervention Type
Procedure
Intervention Name(s)
autologous bone marrow stem cells
Other Intervention Name(s)
infertility, severe intrauterine adhesions, endometrial dysplasia, collagen scaffold
Intervention Description
Before considering whether patients meet the inclusion criteria, they are diagnosed with severe intrauterine adhesions uterus, endometrial dysplasia. And after that there will be history taking, physical examination, chromosome examination, B-ultrasound examination, hysteroscopy examination and so on.
If patients agree to participate, they will receive a bone marrow stem cells collection and separation of adhesions by hysteroscopy surgery. Postoperative observation period is about three months, including B-ultrasound examination once a month and hysteroscopy after 3 months. According to the endometrial conditions, the doctor will select an appropriate time for pregnancy and follow-up. The doctor may also require patients to do some unscheduled visits.
Primary Outcome Measure Information:
Title
Reduction of intrauterine scar area,the change of intrauterine adhesion
Description
hysteroscope ,understanding improvement of uterine cavity form,the degree and nature of adhesion or the vanishment of intrauterine adhesion,and the reduction of scar and its area,comparing with pre-operation
Time Frame
up to 3 months
Secondary Outcome Measure Information:
Title
The change of endometrial thickness
Description
Measure the endometrial thickness and endometrial blood supply during ovulation by ultrasound by the same trained medical sonographers,comparing with pre-operation.
Time Frame
up to 1 month
Title
The change of endometrial thickness
Description
Measure the endometrial thickness and endometrial blood supply during ovulation by ultrasound by the same trained medical sonographers,comparing with pre-operation.
Time Frame
up to 2 months
Title
menstrual blood volume The change of menstrual blood volume
Description
Understanding the menstrual blood volume after surgery ,the number of sanitary napkins per day ,and number of days,comparing with pre-operation.
Time Frame
baseline and 1 month
Other Pre-specified Outcome Measures:
Title
rate of pregnancy
Time Frame
2 years
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Infertility caused by serious intrauterine adhesions or endometrial dysplasia
Hysteroscopy examination confirmed intrauterine adhesions or endometrial dysplasia
Monitoring of endometrial cycle
Sign a consent form
Follow the test plan and follow-up process
Exclusion Criteria:
Abnormal chromosome karyotype
Congenital uterine malformations
Severe endometriosis
Severe adenomyosis
Contraindications to pregnancy
Contraindications to bone marrow collection
Contraindications to hormone replacement therapy
Medical history of pelvic tumors or receiving pelvic radiotherapy
Unable to adhere to the hospital examination and follow-up, or carrying on other treatment during follow-up period
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yali Hu, MD PhD
Phone
02583304616
Ext
66808
Email
819241652@qq.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yali HU, MD,PhD
Organizational Affiliation
Vice-president of the Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nanjing Drum Tower Hospital
City
Nanjing
State/Province
Jiangsu
ZIP/Postal Code
210008
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yali HU, MD,PhD
Phone
02583304616
Ext
66808
Email
dtylhu@126.com
12. IPD Sharing Statement
Learn more about this trial
Treatment of Infertility by Collagen Scaffold Loaded With Autologous Bone Marrow Stem Cells
We'll reach out to this number within 24 hrs